Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 20 (CICP20) is a human pseudogene belonging to the family of capicua transcriptional repressor pseudogenes. Pseudogenes are genomic DNA sequences that resemble functional genes but are generally considered non-functional due to mutations or lack of regulatory elements required for expression. There are no functional proteins, known therapeutic implications, or disease associations reported for CICP20—it does not encode an active transcriptional repressor and is not a characterized drug target or biomarker. The *functional* Capicua transcriptional repressor (gene symbol: CIC) is a high mobility group (HMG)-box containing transcriptional repressor protein implicated in several physiological and disease processes, including neurodevelopment and cancer. CICP20 is one of several pseudogenes for CIC and does not share these functional attributes. No information is available regarding its utility in therapeutics, diagnostics, or as a biomarker, thus it is not considered a target by pharmacological definitions. This entry is most accurately classified as a genomic pseudogene and not a target molecule or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 20 (CICP20).